UVEAL MELANOMA? 5-6 Adults Per Million Are If UM Is Suspected, Patients Should Uveal Melanoma (UM) Is a Cancer That Arises in the Uvea
Total Page:16
File Type:pdf, Size:1020Kb
WHAT IS UM IN NUMBERS DIAGNOSIS UVEAL MELANOMA? 5-6 adults per million are If UM is suspected, patients should Uveal Melanoma (UM) is a cancer that arises in the uvea. diagnosed with UM each year. be referred to an eye cancer specialist, The uvea is a pigmented layer of the eye which includes known as “ocular oncologist”. the choroid, the ciliary body and the iris. UM is often also called ocular melanoma. However, this term includes the even rarer conjunctival melanoma, which is biologically similar to It is important to have skin melanomas and behaves very differently from UM. regular eye exams. Most people show no symptoms at all, CHOROID UM can affect anyone. and detection happens only on routine eye examination, using eye drops to But it is more common in people: UVEA CILIARY BODY dilate the pupil. Diagnosis is confirmed • between 50 and 70 years old with tests, such as ultrasounds, IRIS • that are white, slightly more in men angiograms and biopsies. • with blue or green eyes Disease outside the eye region develops LENS • with moles inside the eye almost exclusively in patients whose CORNEA (uveal nevi, congenital ocular tumour in the eye shows specific melanosis or melanocytoma) melanoma changes in genetic material (loss of a SCLERA OPTIC NERVE • in rare cases, UM is associated with of the iris chromosome 3, and other factors). RETINA the BAP1 predisposition syndrome, CONJUNCTIVA melanoma melanoma where familiar transmission can occur of the ciliary body of the choroid Ask your ocular oncologist how Possible signs and symptoms: a biopsy may influence your Choroid: blood filled layer of pigmented tissue under the retina. • seeing flashes of light care – both from a treatment Ciliary Body: muscular ring, which adjusts the focus of the lens • blurred or distorted vision and follow-up perspective. and pumps fluid into the eye to maintain the shape of the eyeball. • changes in the appearance of the eye Iris: controls the amount of light that enters the eye. • irritation and pain (rare) Lens: focuses light behind the iris onto the retina. TREATMENT OF THE Cornea: transparent “window” at the front of the eye. CANCER IN THE EYE Sclera: leathery white “bag” which holds the eye together. Treatment choice is based on: Retina: light-sensitive “film” at the back of the eye, which provides sight. Up to 50% of • how much the patient’s sight is affected Conjunctiva: transparent “skin” covering the eye and lining UM can grow and UM patients develop • size and location of the tumour the inside of the eyelids. spread to distant organs metastases from • pathology reports Optic Nerve: transmits visual information from the retina to the brain. to form new tumours the time of initial • general health of the patient called metastases. The liver diagnosis to several is a common place but the decades later. lungs, bone, skin and more rarely the brain can also There may be different be involved. treatment choices, typically: If the tumour is small and It is important to discuss a not involving the optic nerve: If the tumour is large: surveillance strategy, namely liver • radiotherapy • enucleation (eye removal) (brachytherapy or proton beam therapy) scans, with your ophthalmologist • rarely, exenteration • local resection (eye and adjacent tissue removal) Deutsch English Español Français Italiano Nederlands Polski Português and/or oncologist to watch for • more rarely, laser treatment Stay up to date and find out more @ umcure2020.org potential metastases. (photodynamic therapy or others) SURVEILLANCE MANAGING GET METASTATIC DISEASE INVOLVED Unfortunately, UM metastases umcure2020.org Patients should discuss with their rarely respond to treatment. specialist what tests would be best for Clinical trials may offer the best Patients can contribute significantly to the them to detect any metastases in other possibility for disease management. understanding of uveal melanoma and the parts of the body, how frequently these should be done and for how long. development of appropriate research models to find new therapies. This surveillance protocol should be adjusted If metastases are suspected, according to the risk of metastatic disease, which a multidisciplinary approach in may be estimated by considering clinical findings as a reference centre specialised HOW? well as pathology and genetic results. in uveal melanoma • By donating part of their biopsy or surgical samples For checking the liver, MRI (Magnetic Resonance to reference centres’ biobanks. Research using these Imaging) is currently thought to be the optimal should be sought. samples can lead to new clinical trials dedicated to choice in many countries. Depending on the features and location of metastatic UM patients. metastases, the patient may be a candidate for targeted therapy, surgery, immunotherapy, • By working with patient organisations, such as radiotherapy and/or liver-directed therapies MPNE (and associated national networks), who (chemosaturation, chemoembolization, radioembolization). partner and have a direct input into research projects and how new clinical trials are designed. In patients with only one or few localized metastases in the liver, surgical resection of the affected areas can be considered. FINDING REFERENCE CENTRES AND ONGOING CLINICAL TRIALS FINDING SUPPORT More about clinical trials at: umcure2020.org/trials UM CURE 2020 reference centres are: • Institut Curie: umcure2020.org/curie • Liverpool Ocular Oncology Centre: umcure2020.org/looc and umcure2020.org/loorg • Melanoma Patient Network Europe (MPNE): • Leiden University Medical Center: umcure2020.org/lumc melanomapatientnetworkeu.org • Jagiellonian University: umcure2020.org/jagiellonian • MPNE Rare Ocular, Mucosal, Acral & Paediatric Discuss with your oncologist if you Facebook Group: umcure2020.org/mpne are eligible for an ongoing clinical trial. version 2, 2019 Stay up to date @ umcure2020.org.